Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-28

Clinical Trial Update: Fetal and Infant Effects of Maternal Buprenorphine Treatment [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update examining fetal and infant effects of maternal buprenorphine treatment in neonatal abstinence syndrome, with completed Phase 2 and Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Neonatal Abstinence Syndrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-08-28